Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round

It took four tries over four years, but Perrigo has finally gotten over the finish line with its generic of Teva’s tricky-to-make ProAir HFA inhaler for chronic obstructive pulmonary disease and asthma.